Cubist Systematic Strategies, LLC Graybug Vision, Inc. Transaction History

Cubist Systematic Strategies, LLC

  • $15.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$1.74 - $3.6 $17,781 - $36,788
-10,219 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$3.18 - $5.17 $29,605 - $48,132
-9,310 Reduced 47.67%
10,219 $34,000
Q2 2021

Aug 16, 2021
SELL
$3.53 - $6.1 $145,753 - $251,868
-41,290 Reduced 67.89%
19,529 $106,000
Q1 2021

May 17, 2021
BUY
$5.55 - $35.0 $337,545 - $2.13 Million
60,819 New
60,819 $338,000

Others Institutions Holding GRAY

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About GRAYBUG VISION, INC.

GRAY Quotes by TradingView
  • Ticker GRAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,517,700
  • Market Cap $63.5M
  • Description
  • Graybug Vision, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the t...
More about GRAY
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email